Changes in Trends in Thyroid Cancer Incidence in the United States, 1992 to 2016

Ann E. Powers; Andrea R. Marcadis; Mark Lee; Luc G.T. Morris; Jennifer L. Marti

doi:10.1001/jama.2019.18528

Changes in Trends in Thyroid Cancer Incidence in the United States, 1992 to 2016

Ann E. Powers, Andrea R. Marcadis, Mark Lee, Luc G.T. Morris, Jennifer L. Marti

Icahn School of Medicine at Mount Sinai

Research output: Contribution to journal › Letter › peer-review

60 Scopus citations

Original language	English
Pages (from-to)	2440-2441
Number of pages	2
Journal	JAMA - Journal of the American Medical Association
Volume	322
Issue number	24
DOIs	https://doi.org/10.1001/jama.2019.18528
State	Published - 24 Dec 2019

Access to Document

10.1001/jama.2019.18528

Cite this

@article{5a46009fabd54e919d325e274bbe93a8,

title = "Changes in Trends in Thyroid Cancer Incidence in the United States, 1992 to 2016",

author = "Powers, {Ann E.} and Marcadis, {Andrea R.} and Mark Lee and Morris, {Luc G.T.} and Marti, {Jennifer L.}",

note = "Funding Information: Author Affiliations: Icahn School of Medicine at Mount Sinai, New York, New York (Powers); Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York (Marcadis, Morris); Department of Surgery, Weill Cornell Medicine, New York, New York (Lee, Marti). Accepted for Publication: October 22, 2019. CorrespondingAuthor:JenniferL.Marti,MD,DepartmentofSurgery,WeillCornell Medicine, 420 E 70th St, New York, NY 10065 ([email protected]). Author Contributions: Drs Morris and Marti, who jointly supervised the work and share senior authorship, had full access to the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: All authors. Acquisition, analysis, or interpretation of data: Powers, Marcadis, Lee, Morris. Drafting of the manuscript: Powers, Marcadis, Lee, Morris. Critical revision of the manuscript for important intellectual content: All authors. Statistical analysis: Powers, Marcadis, Lee, Morris. Administrative, technical, or material support: Marcadis, Morris. Supervision: Morris, Marti. Conflict of Interest Disclosures: Dr Morris reported receipt of personal fees from Rakuten Aspyrian; in addition, the Morris laboratory receives research funding from Illumina Inc and AstraZeneca for laboratory research. No other disclosures were reported. Additional Contributions: We acknowledge Jill Gregory, CMI, and Ni-ka Ford, MS, Icahn School of Medicine at Mount Sinai, for their uncompensated assistance with the Figure. 1. Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. JAMA. 2017;317(13): 1338-1348. doi:10.1001/jama.2017.2719 2. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295(18):2164-2167. doi:10.1001/jama.295.18.2164 3. Furuya-Kanamori L, Bell KJL, Clark J, Glasziou P, Doi SAR. Prevalence of differentiated thyroid cancer in autopsy studies over six decades: a meta-analysis. J Clin Oncol. 2016;34(30):3672-3679. doi:10.1200/JCO.2016.67.7419 4. Ahn HS, Welch HG. South Korea{\textquoteright}s thyroid-cancer “epidemic”—turning the tide. N Engl J Med. 2015;373(24):2389-2390. doi:10.1056/NEJMc1507622 5. Bibbins-DomingoK,GrossmanDC,CurrySJ,etal;USPreventiveServicesTaskForce. Screening for thyroid cancer: US Preventive Services Task Force recommendation statement. JAMA. 2017;317(18):1882-1887. doi:10.1001/jama.2017.4011 6. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26 (1):1-133. doi:10.1089/thy.2015.0020",

year = "2019",

month = dec,

day = "24",

doi = "10.1001/jama.2019.18528",

language = "English",

volume = "322",

pages = "2440--2441",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "24",

}

TY - JOUR

T1 - Changes in Trends in Thyroid Cancer Incidence in the United States, 1992 to 2016

AU - Powers, Ann E.

AU - Marcadis, Andrea R.

AU - Lee, Mark

AU - Morris, Luc G.T.

AU - Marti, Jennifer L.

N1 - Funding Information: Author Affiliations: Icahn School of Medicine at Mount Sinai, New York, New York (Powers); Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York (Marcadis, Morris); Department of Surgery, Weill Cornell Medicine, New York, New York (Lee, Marti). Accepted for Publication: October 22, 2019. CorrespondingAuthor:JenniferL.Marti,MD,DepartmentofSurgery,WeillCornell Medicine, 420 E 70th St, New York, NY 10065 ([email protected]). Author Contributions: Drs Morris and Marti, who jointly supervised the work and share senior authorship, had full access to the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: All authors. Acquisition, analysis, or interpretation of data: Powers, Marcadis, Lee, Morris. Drafting of the manuscript: Powers, Marcadis, Lee, Morris. Critical revision of the manuscript for important intellectual content: All authors. Statistical analysis: Powers, Marcadis, Lee, Morris. Administrative, technical, or material support: Marcadis, Morris. Supervision: Morris, Marti. Conflict of Interest Disclosures: Dr Morris reported receipt of personal fees from Rakuten Aspyrian; in addition, the Morris laboratory receives research funding from Illumina Inc and AstraZeneca for laboratory research. No other disclosures were reported. Additional Contributions: We acknowledge Jill Gregory, CMI, and Ni-ka Ford, MS, Icahn School of Medicine at Mount Sinai, for their uncompensated assistance with the Figure. 1. Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. JAMA. 2017;317(13): 1338-1348. doi:10.1001/jama.2017.2719 2. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295(18):2164-2167. doi:10.1001/jama.295.18.2164 3. Furuya-Kanamori L, Bell KJL, Clark J, Glasziou P, Doi SAR. Prevalence of differentiated thyroid cancer in autopsy studies over six decades: a meta-analysis. J Clin Oncol. 2016;34(30):3672-3679. doi:10.1200/JCO.2016.67.7419 4. Ahn HS, Welch HG. South Korea’s thyroid-cancer “epidemic”—turning the tide. N Engl J Med. 2015;373(24):2389-2390. doi:10.1056/NEJMc1507622 5. Bibbins-DomingoK,GrossmanDC,CurrySJ,etal;USPreventiveServicesTaskForce. Screening for thyroid cancer: US Preventive Services Task Force recommendation statement. JAMA. 2017;317(18):1882-1887. doi:10.1001/jama.2017.4011 6. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26 (1):1-133. doi:10.1089/thy.2015.0020

PY - 2019/12/24

Y1 - 2019/12/24

UR - http://www.scopus.com/inward/record.url?scp=85077044562&partnerID=8YFLogxK

U2 - 10.1001/jama.2019.18528

DO - 10.1001/jama.2019.18528

M3 - Letter

C2 - 31860035

AN - SCOPUS:85077044562

SN - 0098-7484

VL - 322

SP - 2440

EP - 2441

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 24

ER -